These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20962673)

  • 1. Establishment, characterization, and drug sensitivity of a new Ewing sarcoma cell line (SS-ES-1).
    Rajabalian S; Hajializadeh Z; Pooraboli I; Jangi-Aghdam H; Badinloo M
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e331-7. PubMed ID: 20962673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
    Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
    J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.
    O'Sullivan MJ; Perlman EJ; Furman J; Humphrey PA; Dehner LP; Pfeifer JD
    Hum Pathol; 2001 Oct; 32(10):1109-15. PubMed ID: 11679946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
    Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
    Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Ewing sarcoma/peripheral primitive neuroectodermal tumor of the vulva.
    Fong YE; López-Terrada D; Zhai QJ
    Hum Pathol; 2008 Oct; 39(10):1535-9. PubMed ID: 18602673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
    Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary extraskeletal Ewing family tumor with complex epithelial differentiation: a unique case arising in the lateral neck presenting with Horner syndrome.
    Weinreb I; Goldstein D; Perez-Ordoñez B
    Am J Surg Pathol; 2008 Nov; 32(11):1742-8. PubMed ID: 18769338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
    Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
    Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biology of Ewing sarcoma.
    Riggi N; Stamenkovic I
    Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
    Wang H; Zheng J; Wang YP; Yang Y; You JF
    Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing's sarcoma family of tumors: current management.
    Bernstein M; Kovar H; Paulussen M; Randall RL; Schuck A; Teot LA; Juergens H
    Oncologist; 2006 May; 11(5):503-19. PubMed ID: 16720851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
    Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse.
    Huang HY; Illei PB; Zhao Z; Mazumdar M; Huvos AG; Healey JH; Wexler LH; Gorlick R; Meyers P; Ladanyi M
    J Clin Oncol; 2005 Jan; 23(3):548-58. PubMed ID: 15659501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS; Burchill SA
    Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.